A detailed insight into the interaction of memantine with bovine serum albumin: A spectroscopic and computational approach

Publication date: 1 April 2020Source: Journal of Molecular Liquids, Volume 303Author(s): Faisal Ameen, Sharmin Siddiqui, Ishrat Jahan, Shahid M. Nayeem, Sayeed ur Rehman, Mohammad TabishAbstractMemantine is an NMDA receptor antagonist used to treat Alzheimer's disease. Detailed insight about the interaction between memantine and bovine serum albumin (BSA) was obtained through multi spectroscopic techniques and in silico analysis. UV–visible, steady-state fluorescence spectra, and resonance light scattering (RLS) studies showed the complex formation between memantine and BSA. The binding constant for the BSA-memantine complex was found to be in the order of 103 M−1. The local structural changes in BSA induced by memantine were detected by synchronous fluorescence spectroscopy (SFS), three-dimensional fluorescence and circular dichroism. The study of NaCl effect, as well as molecular docking, revealed the existence of electrostatic interaction in the complex formation. Binding constant was calculated in the presence of metal ions and their different combinations. Site marker fractional occupancy indicated that memantine binds to site IB of BSA. Additionally, the CD-based thermal unfolding profile showed that memantine has stabilizing effects on BSA. Molecular dynamics simulations further provided information on the stability and the forces involved in the binding of memantine with BSA.Graphical abstract
Source: Journal of Molecular Liquids - Category: Molecular Biology Source Type: research

Related Links:

This study examines knowledge, attitudes, and beliefs about brain donation for research among Latinos. Latino men (N=4) and Latina women (N=11) 18 years of age or older with a parental figure age 65 years and over were invited to participate in a focus group. RESULTS: Data analyses revealed 3 themes. Two themes focused on factors influencing a family's willingness to support brain donation: (a) social and cultural contexts, and (b) lack of knowledge and information about the brain donation process. The last theme provided recommendations for engaging older Latino adults in ADRD research and brain donation. DISCUSSI...
Source: Alzheimer Disease and Associated Disorders - Category: Psychiatry Tags: Alzheimer Dis Assoc Disord Source Type: research
Authors: Culhane JE, Chan KCG, Teylan MA, Chen YC, Mock C, Gauthreaux K, Kukull WA Abstract The proprietary neuropsychological tests (Form C1) of the National Alzheimer's Coordinating Center (NACC) Uniform Data Set were replaced with nonproprietary versions (Form C2) chosen to closely model their proprietary counterparts. Correlations between analogous test pairs as measured in previous work were good (0.68-0.78), but it is unclear whether the paired tests represent the same set of common factors of cognition or if important factors specific to C1 or C2 only exist. The authors performed multiple factor analysis to ...
Source: Alzheimer Disease and Associated Disorders - Category: Psychiatry Tags: Alzheimer Dis Assoc Disord Source Type: research
DISCUSSION: Developing strategies to circumvent the development of maladaptive behaviors could significantly reduce morbidity and mortality in MCI patients. PMID: 32218064 [PubMed - as supplied by publisher]
Source: Alzheimer Disease and Associated Disorders - Category: Psychiatry Tags: Alzheimer Dis Assoc Disord Source Type: research
Action of low doses of Aspirin in Inflammation and Oxidative Stress induced by aβ1-42 on Astrocytes in primary culture. Int J Med Sci. 2020;17(6):834-843 Authors: Jorda A, Aldasoro M, Aldasoro C, Guerra-Ojeda S, Iradi A, Vila JM, Campos-Campos J, Valles SL Abstract Aspirin has been used as anti-inflammatory and anti-aggregate for decades but the precise mechanism(s) of action after the presence of the toxic peptide Aβ1-42 in cultured astrocytes remains poorly resolved. Here we use low-doses of aspirin (10-7 M) in astrocytes in primary culture in presence or absence of Aβ1-42 toxic peptid...
Source: International Journal of Medical Sciences - Category: Biomedical Science Tags: Int J Med Sci Source Type: research
ConclusionsSex hormone action on cell viability is dependent on the cellular environment. In healthy neuronal cells, sex hormones are protective against oxidative stress insults via the estrogen receptor, regardless of sex chromosome complement (XX, XY). However, in unhealthy (e.g., high oxidative stress) cells, sex hormones exacerbated oxidative stress-induced cell loss, regardless of cell type or sex chromosome complement. The non-genomic AR45 receptor, which is present in humans, mediated androgen ’s damaging effects, but it is unknown which receptor mediated estrogen’s damaging effects. These differential e...
Source: Biology of Sex Differences - Category: Biology Source Type: research
CONCLUSIONS DEGs, including SORT1, CRYAB, PSMA1, and SDHA may have roles in the pathogenesis of PD through the MAPK, Wnt, and Notch signaling pathways. PMID: 32210219 [PubMed - in process]
Source: Medical Science Monitor - Category: Research Tags: Med Sci Monit Source Type: research
PMID: 32209035 [PubMed - in process]
Source: Current Alzheimer Research - Category: Neurology Authors: Tags: Curr Alzheimer Res Source Type: research
CONCLUSIONS: WM pathology is strongly associated with impaired processing speed, and our results indicate that these impairments arise from WMH in the temporal and parieto-occipital regions. In MCI and AD patients with temporal WMH, processing speed impairments are especially prominent. The results of this study increase our knowledge of cognitive repercussions stemming from temporal and/or parieto-occipital WM pathology in healthy and pathological aging. PMID: 32209796 [PubMed - as supplied by publisher]
Source: Dementia and Geriatric Cognitive Disorders - Category: Psychiatry Tags: Dement Geriatr Cogn Disord Source Type: research
Authors: Khachaturian AS, Hayden KM, Devlin JW, Fleisher LA, Lock SL, Cunningham C, Oh ES, Fong TG, Fick DM, Marcantonio ER, Iyengar V, Rockwood K, Kuchel GA, Eckenhoff RG, MacLullich AMJ, Jones RN, Davis D, D'Antonio PM, Fargo KN, Albert MS, Williamson JD, Ling SM, Weiss J, Karlawish J, Petersen RC, Blazer DG, Khachaturian ZS, Inouye SK PMID: 32212231 [PubMed - as supplied by publisher]
Source: The Journal of Alzheimers Association - Category: Psychiatry Tags: Alzheimers Dement Source Type: research
Daily low-dose aspirin as prevention therapy takes another hit, this time for not reducing risk of Alzheimer's disease or cognitive impairment in a large randomized study.Medscape Medical News
Source: Medscape Neurology and Neurosurgery Headlines - Category: Neurology Tags: Neurology & Neurosurgery News Source Type: news
More News: Alzheimer's | Molecular Biology | Namenda | Study